CIRO Trader study materials
CIRO Trader study resources

CIRO Trader case studies

CIRO Trader · Put your knowledge to work in context.

The CIRO Trader credential is a Canadian securities licence category for individuals who buy and sell securities on behalf of clients or for a dealer's own account. It sits within the proficiency framework administered by the Canadian Investment Regulatory Organization, which sets the standards a registered representative must meet before conducting trading activity. The CIRO Trader case studies are 5 cases and about 2,894 words.

1

The Block Cross That Wasn't Really a Cross

A dealer at a Toronto institutional desk arranges a 400,000-share cross of a mid-cap issuer between two client accounts at a price 1.2% below the last sale. The dealer books both sides internally, prints a single cross trade on the exchange, and reports the trade within the required window.

587 words, about 3 min
2

The Bond Markup Nobody Questioned

A retail client buys $250,000 face value of a corporate bond from a dealer at a price of 101.75. The dealer acquired the bonds 20 minutes earlier at 100.10 from another dealer.

600 words, about 3 min
3

The Option Overlay That Doubled the Risk

A client with a balanced portfolio and a stated maximum drawdown tolerance of 10% is pitched a structured note linked to an equity index. The note pays a coupon of 6% annually but includes a knock-in barrier at 70% of the initial index level.

607 words, about 3 min
4

The Layering Pattern in a Thin Stock

A proprietary trader at a small broker-dealer trades a thinly traded small-cap stock. Over three days, the surveillance system flags a pattern: the trader enters several large buy orders on the visible book at prices just below the offer, cancels them within seconds, and simultaneously executes smaller sell orders at the offer.

544 words, about 3 min
5

The Discretionary Account That Wasn't

An advisor manages a discretionary account for a client with a conservative profile and a 5% maximum equity allocation. Over two months, the advisor buys three small-cap biotech stocks, bringing equity exposure to 22%.

556 words, about 3 min